TrialClinical pharmacokinetics2020

Pharmacokinetics, Safety, and Tolerability of Selonsertib, an Apoptosis Signal-Regulating Kinase 1 (ASK1) Inhibitor, Following First-in-Human Single and Multiple Ascending Doses in Healthy Subjects.

Cara H Nelson et al.PubMed ↗Publisher ↗

No numbers read from the abstract.